Cytoskeletal-antigen specific immunoliposomes: a therapeutic breakthrough in preservation of ischemic myocardium.
To demonstrate (1) preservation of myocardial function and integrity following targeted cytoskeleton-specific immunoliposome (CSIL) treatment of globally ischemic myocardium, (2) a dose response and (3) a time response to treatment. Cell membrane lesion sealing of hypoxic cardiocytes in culture with...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/D20234895 |